background image

Transforming the way we treat obesity and diabetes.

Gelesis is a biotechnology company developing a novel category of therapies to safely induce weight loss and improve glycemic control in overweight and obese patients.

Gelesis100, our lead product, is a first-in-class therapeutic which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Gelesis100 is administered orally as a capsulated device.